Medicines
The Delhi High Court has ruled in favour of Pharmacyclics LLC and Johnson & Johnson Pvt Ltd (Johnson & Johnson) in a patent infringement suit moved by them for violation of their rights in targeted cancer treatment drug, Ibrutinib, marketed as Imbruvica. Find out all about the case here.
Read Full Article
Can the Preamble of the Constitution be amended during an emergency? Explore constitutional, legal, and ethical questions surrounding the 42nd Amendment.
23 November, 2024 10:03 PM
![Pharmacyclics, Johnson & Johnson win patent infringement suit for anti-cancer drug [Read Judgment]](/secure/uploads/2024/01/lj_5765_WhatsApp_Image_2024-01-03_at_5.45.56_PM.jpeg)
